Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
| Return to All Pharma Marketing Blog Topics |
The following Pharma Marketing Blog topics focus on specific pharmaceutical companies. If your company is not listed here, don't worry. It will be sooner or later!
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
Posts are listed in reverse chronological order:
-
Allergan
- Botox BS Piled Higher and Deeper
- Introducing...the All-Pharma Lobbying Lineup!
- What Was Blogworthy in 2006? A Review
- Allergan Ignores Guidelines, Wins Award Anyway
- PhRMA Intern vs. BOTOX!
- Dear AstraZeneca: Please Invite Me to a Screening ...
- AZ's Missy Moran's MUMS Miasma
- 'Round the Sphere: You're Fired!
- Group of 7 (code name "whiskey") Reports Unethical AZ Behavior to OIG
- The Zubillaga Affair: Effect on the Prospects for Pharma Blogging
- AstraZeneca's Risky Proposition
Bayer
- Marketing Drugs to Teens Online - So Wrong!
- If FDA were as Powerful as FTC
- Another Pharma CEO Bites the Dust!
- Centocor: Let Thy Employees Speak!
- Centocor Blog - No Frying Pan and No Fire!
- CNTO411: Centocor's Groundbreaking Blog
- No Oscar for Centocor PR Effort
- Nice Try, Daiichi!
- Lilly, Sweden, Bribes and Conspiracy Theories
- Lilly Cymbalta Marketers are NOT Practicing What Lilly Executives Preach!
- Lilly Cuts PAP and Runs from Patients in Need, Putting Profits First
- eGAD! How I Learned to Stop Worrying and Love Cymbalta!
- Introducing...the All-Pharma Lobbying Lineup!
- Lilly's Off-Label Promo Shenanigans
- Introducing...the All-Pharma Lobbying Lineup!
- PGAD. EGAD! Another Syndrome/Disorder, Whatever!
- Dr. Buse Under GSK's Thumb! How Pharma Uses CME Funding as a Weapon.
- RLS Foundation (aka GSK?) Calls for Boycott of Consumer Reports Over Ad Spoof
- What's Up with the Veramyst "Brief Summary" Print Ad?
- GSK's Race-based Herpes Awareness Campaign
- The "RLS Gene" Story: Requip Ad Disguised as News on ABC
- It Was Politics That Killed Avandia, Says Glaxo
- GSK May "Step Into the [DTC] Void" to Defend Avandia
- Advice to GSK on Handling the Avandia Avalanche: Don't Do What Merck Did
- Pharma Still Stinks, But Not as Much as Oil or Tobacco!
- GSK Pulls Imus Ads...BUT, Only Until "Media Standards" Are Met
- Glaxo, Pull Your Imus Ads!
- Marketing Drugs to Teens Online - So Wrong!
- Alli Oops! I Just Pooped Myself!
- GSK: Don't Go Cold Turkey!
- The Call Center from Hell
- Patient Advocacy Marketing: US vs Them
- GSK's "Plain Talk" Flawed
- J&J Blog, Shire PR: The Whole Story and Nothing But the Whole Story!
- J&J Lawyers Go Wild; PR on Vacation!
- Advice to All Pharma PR Bloggers Out There
- J&J to Give 120,000 Employees Their Own Blogs?
- Device DTC Ad Spend Sinks: Trend or Anomaly?
- J&J, You're No Elvis Presley!
- J&J Scores High in Reputation Quotient Study
- Say it isn't so, J&J!
Merck
- Vytorin Study Stallin' - Notes from the Field Hands
- Merck to Vioxx Plaintiffs: Settle or Else!
- Gardasil: Is the Risk of Being "One Less" Worth It?
- Mandatory Vaccination Controversy Did Not Hurt Gardasil Sales!
- Why Grow Your Own Drugs When You Can Buy Them Off the Street?
- Rejiggering the Marketing Mix a la Merck
- Gardasil: Less Hype May Help
- Does Merck Need a Vaccine for Bad PR?
- Merck's Refreshing Director of Global eMarketing
- Who's Easier to Buy? A Physician or a Politician?
- Merck Quits Lobbying for Mandatory Gardasil Vaccination
- Gardasil: To Be Mandatory or Not To Be Mandatory -- That is the Question
- Merck on a Roll
- Out with the Bad, In with the Good
- Odds & Ends & Interpretations
- Merck Management Is "Exonerated"
- Vioxx Scorecard: 5-3-14192
- We Were Hoodwinked!
- Merck Misled FDA According to NJ Jury
- Merck's Hand in the Cookie Jar
- Merck to Shed Fat, But Not in Sales & Marketing
- Saving Public Merck
- Merck Changes Tactics, Lawyers Too
- Merck science "like wah, wah, wah"
- Merck Found Negligent!
- Patients Come First?
- John Mack Rebuffs Mercks CEO Offer
- Who Should Pay for Merck's Obstructionism?
Novartis
- My Prediction Vindicated: FluFlix Contest Entrants Will Sign Over Video Rights
- Novartis Attempts Perfect Execution of Web 2.0 Trick!
- New Twist to Pharma Chatchke Marketing: the Scrubs Affair
- Pfizer Reneges on DTC Pledge: Afternoon Viagra Ads...
- Did Pfizer Run a Chantix "Bookend" Ad During 60 Minutes?
- Pfizer the Headless Chicken!
- Exubera: A Titanic Failure! What the survivors are saying.
- Pfizer has a Gold Mine in Sermo!
- Viva Viagra Ad is No Cure for Morte Sales
- Exubera TV Ad Lacks Bong, er, I mean Bang!
- What do Abe Lincoln, a beaver, and a bong have in common?
- Is Pfizer Outsourcing Innovation?
- Are you happy to see me, or is that just your Exubera Bong?
- Pfizer PhD Phobia
- Prilosec OTC Bunco Artists
- Introducing...the All-Pharma Lobbying Lineup!
- Viagra Spray Not Far Away?
- What Was Blogworthy in 2006? A Review
- Celebrex Joins the bAdWord Bandwagon!
- Tufts Hangs Tough on Opportunity Cost Analysis
- Is Pfizer Arrogant and Superior?
- Betting the Pharm
- torcetrapib: "$800 Million" Failure but Kindler Safe
- Pfizer's torcetrapib: Who Knew What, When?
- Out with the Bad, In with the Good
- Wooing Dems: Thank You Mr. Kindler!
- Pharma's Black Knight Parties On!
- Kindler, Cheney: Kindred Spirits?
- Kindler Fox in Pfizer Henhouse (aka Bunker)
- Pfizer Imitating Art or Vice Versa?
- Pfizer - the Rodney Dangerfield of the Drug Industry
- Pfizer Tries Unbranded ED DTC Ads
- Pfizer No Longer Top 10 Advertiser
- Pfizer DTC Pledge: ED is Litmus Test
- Cox-2's (and Pfizer?) on Slippery Slope
- Pfizer to Slash 30% of its Sales & Marketing Staff
Roche Therapeutics
- If FDA were as Powerful as FTC
- Acomplia Not for the Gun Totting Bikini Crowd
- Need More Moth? Try This!
- Zetia "49 Strategy" -- Wine and Dine 'em Danno!
- Sepracor Not So Keen to Spend Big on DTC for Its Next Product!
- Lunesta Moth Being Mothballed as a Result of Negative Marketing ROI
- Introducing...the All-Pharma Lobbying Lineup!
- Revamping the Lunesta Ad Campaign
- PhRMA's OOA Issues First Report
- Lunesta, a Sleeping Dog
- The Adventures of PhRMA Intern!
- Sepracor Sneaks In Lunesta Reminder Ad
- Another Award for Rozerem! This one...not so good.
- Rozerem Expedites Experts' Dreams: Honoraria!
- Rozerem Ad Spending Exceeds Sales!
- Rozerem Over There? Sic 'em Beav!
- Takeda - Fire These Guys!
- Call for a Rozerem Prescription Boycott!
- Back to School for Takeda, Rozerem, and Abe Lincoln!
- Lincoln Shot Dead! Beaver Sought for Questioning
- PhRMA Responds to My Rozerem Ad "Concern"
- Tilting Again at the PhRMA Windmill
- Takeda: It Isn't a Reminder Ad --- Wha!!!
- Rozerem Reverts to Reminder TV Ads
- Lincoln Shot Dead! Beaver Sought for Questioning
- Dr. Carlat's True Confession: 199,999 More to Go
AstraZeneca
Bristol-Myers Squbb
Centocor
Daiichi Sankyo, Inc.
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Organon
Pfizer
Sanofi
Schering-Plough
Sepracor
Takeda Pharmaceuticals
Wyeth Pharmaceuticals